The Nuclear Medicine Department of the Second Hospital of Shandong University was formerly known as the Department of Nuclear Medicine of Shandong Medical College. It was founded in 1958. It is one of the earliest units in China to carry out nuclear medicine imaging and treatment. It has undertaken nuclear medicine teaching and postgraduate teaching works of Shandong Medical College since 1959. It has leaded the compiling of the state-compiled textbook “Nuclear Medicine” (1-4 Editions) of the Ministry of Health. At the same time, it has undertaken the training of nuclear medicine doctors, technicians, and nursing professionals nationwide. It has a certain reputation nationwide and has made outstanding contributions to the development of nuclear medicine in China. Since 1999, it has been incorporated into the Second Hospital of Shandong University. Currently, the Nuclear Medicine Department has 5 medical professionals of various types, including one chief physician and professor, three personnel with a master’s degree, and one senior nurse. In 2009, the Nuclear Medicine Department began to work in a new workplace. It is located on the second floor of the newly-built Medical Technology Building of the hospital. It is about 800 square meters and has a standard radionuclide treatment ward. The nuclear medicine discipline now provides advanced technical support for patient diagnosis and treatment and hospital development with a new look.

Nuclear medicine is a frontier clinical discipline that uses open radionuclides to diagnose and treat diseases. It is composed of professionals with experience in medical imaging and clinical medicine diagnosis and treatment. It is one of the important signs of hospital modernization. The Nuclear Medicine Department is equipped with a SIEMENS dual-probe ECT, which is large and advanced imported equipment. It can perform functional imaging examination of different organs throughout the body. Since 1959, the Nuclear Medicine Department took the lead in the treatment of hyperthyroidism with 131I in Shandong Province, and has treated more than 20,000 people with hyperthyroidism. It has used 131I to treat more than a thousand patients with postoperative metastasis of thyroid cancer, which has a wide-ranging impact in Shandong Province. At the same time, it has carried out 153Sm-EDTMP and 89Sr treatment of bone metastases since 1993. In recent years, this discipline has highlighted the research and diagnosis and treatment directions characterized by nuclide diagnosis of tumors, as well as nuclide treatments of various diseases. At present, it has completed 4 national, provincial and ministerial-level projects, and won 1 Fourth Shandong Youth Science and Technology Award, 7 Shandong Scientific and Technological Achievement Awards. It has published 21 papers in journals including the publications of the Chinese Medical Association, of which 6 papers have been included in PubMed and SCI. It has published 4 books.